Cannatrek C115 Sunstone CBD — TGA-Authorised High-CBD Medicinal Cannabis Flower for Australian Patients – Cannatrek C115 Sunstone CBD
Cannatrek C115 Sunstone CBD Flower — Premium Medicinal Cannabis for Authorised Australian Patients
Cannatrek C115 Sunstone CBD represents the established benchmark in Australian TGA-authorised medicinal cannabis for patients whose treatment plans prioritise cannabidiol as the primary therapeutic agent. Developed by Cannatrek, one of Australia’s most recognised domestic cannabis producers, the Sunstone cultivar was selected and refined specifically for its stable, high-expression CBD genetics and its ability to deliver consistent cannabinoid ratios across successive cultivation cycles. For patients managing chronic pain, anxiety, inflammation-related conditions, or sleep disturbance under medical supervision, a reliable and well-documented CBD flower product is not a luxury. It is a clinical necessity, and C115 Sunstone is built to meet that standard.
The cultivar name Sunstone reflects both the warm aromatic character of the flower and the philosophy Cannatrek has applied to its domestic growing program, which prioritises sunlight-assisted and controlled-environment cultivation methods that allow the plant to express its full cannabinoid and terpene potential. The result is a dried flower product that presents with visual density, strong trichome coverage, and a fragrance profile that experienced patients and clinicians immediately associate with a well-grown, properly cured medicinal-grade cannabis product.
As an established-market product within the Australian medicinal cannabis framework, Cannatrek C115 Sunstone CBD has been through the full regulatory pathway required for legal patient access. It is not a grey-market or unapproved product. Every batch offered through this store is sourced through compliant, licensed supply channels and is accompanied by the batch-specific documentation that authorised patients and their pharmacists require for lawful dispensing and record-keeping.
Cannabinoid and Terpene Profile with Full Batch Specifications
THC Percentage: Cannatrek C115 Sunstone CBD is classified as a high-CBD, low-THC medicinal flower. The delta-9 THC concentration falls within the range typical of established-market CBD-dominant products approved under the Australian therapeutic goods framework, generally at or below two percent total THC by dry weight. Patients should refer to their current batch Certificate of Analysis for the precise THC figure applicable to the specific unit they are dispensed, as minor batch-to-batch variation is normal within this compliant range.

CBD Percentage: The cannabidiol concentration in Cannatrek C115 Sunstone CBD is the defining feature of this cultivar and the primary reason it is prescribed for patients who require non-intoxicating therapeutic cannabis. CBD potency in this product typically falls in the range that positions it firmly in the high-CBD category recognised by Australian prescribers, with figures available on the batch Certificate of Analysis provided with every dispensed unit.
Terpene Profile: The terpene expression of C115 Sunstone is characterised by a warm, slightly floral, and gently earthy aromatic structure. Myrcene contributes a herbal and mildly sedative aromatic base, while ocimene adds a sweet, faintly fruity lift that distinguishes Sunstone from more resinous or fuel-forward cultivars. Pinene and caryophyllene are also present at meaningful concentrations, contributing to the anti-inflammatory and calming character that patients and clinicians associate with this cultivar’s therapeutic profile.
Cultivar Lineage: C115 Sunstone is a proprietary Cannatrek cultivar developed from stable CBD-dominant genetics selected for their consistency of expression across multiple grow cycles. The lineage prioritises cannabinoid ratio stability above all other agronomic traits, ensuring that prescribers can rely on the cultivar performing to specification across the batches they recommend to their patients over time.
Batch Testing: Every batch of Cannatrek C115 Sunstone CBD is independently tested by a NATA-accredited laboratory before release into the supply chain. Testing covers cannabinoid potency, residual solvent screening, heavy metals, pesticide residues, microbial contamination, and moisture content. The resulting Certificate of Analysis is batch-specific and available to patients and pharmacists as part of the dispensing documentation package accompanying each product.
Moisture Content: Moisture content in C115 Sunstone is maintained within the range that preserves flower integrity, prevents mould development during storage, and ensures that the material burns or vaporises evenly during patient use. Over-dried flower loses terpene content and degrades the therapeutic aromatic profile. Under-dried flower carries microbial risk. Cannatrek’s post-harvest curing and packaging process targets the moisture window that balances these competing considerations and delivers flower that retains its character until the patient opens the seal.
Trim Quality: C115 Sunstone is machine-assisted and hand-finished to a trim standard consistent with medicinal-grade cannabis. Sugar leaves are removed to expose trichome-dense bract material, and the buds are handled through the trim and packaging process in a way that minimises mechanical disruption of the resin glands where cannabinoids and terpenes are concentrated. The finished product presents as visually intact, properly structured dried flower with no excessive stem content or loose shake material in the primary fill.
Packaging Freshness Seal: Each unit of Cannatrek C115 Sunstone CBD is sealed in pharmaceutical-grade airtight packaging at the point of production to lock in the cannabinoid and terpene profile at peak freshness. The tamper-evident seal provides patients and pharmacists with immediate visual confirmation that the product has not been opened or compromised between the point of manufacture and the point of dispensing. Patients should store unopened units in a cool, dark environment away from direct light and heat to maximise shelf life.

Authorised Dispensing Logistics and Our Patient Fulfillment Guarantee
Cannatrek C115 Sunstone CBD is a Schedule 8 controlled medicine in most Australian states and territories and is dispensed exclusively to patients holding a valid prescription issued by a TGA-authorised prescribing practitioner. Orders placed through this store are processed in full compliance with applicable state and federal controlled medicine dispensing regulations, and no order will be dispatched without verified prescription documentation on file.
Every order is subject to a pre-shipment quality check that confirms the batch number matches the documentation on file, the packaging freshness seal is intact, the unit weight is correct, and the Certificate of Analysis is included with the dispensing package. This check is completed by trained staff before the order is handed to the carrier, and a record of each check is retained in the dispensing log for regulatory compliance purposes.
Shipping is conducted via an insured freight service with tracked, signature-on-delivery requirements applied to every controlled medicine shipment. The carrier will not release the package without a signature from an authorised recipient at the dispensing address, and the signature record forms part of the chain-of-custody documentation that controlled medicine dispensing regulations require. In the event that a shipment is damaged in transit, our damage claim process is initiated within twenty-four hours of the patient notifying us, and we retain all dispatch photographs, carrier booking records, and batch documentation needed to resolve the matter efficiently and in the patient’s favour wherever regulation permits.
Patients looking to explore the full range of medicinal cannabis formats available through this store, including oils, capsules, and other inhalation and ingestion products, are warmly encouraged to browse the complete collection at https://littlegreenpharma.shop/product-category/concentrates-extracts-inhalation-ingestion/ where additional authorised products are available for prescription-holding patients.
TGA-authorised medicinal cannabis
Cannatrek C115 Sunstone CBD-Frequently Asked Questions














Reviews
There are no reviews yet.